Skip to main content


Table 8 Fracture Risk Reduction in Response to Therapy.

From: Management of osteoporosis

Generic Name Brand Name Spine Fracture Non-Vertebral Fracture Hip Fracture
Estrogen Various
Alendronate Fosamax
Risedronate Actonel
Ibandronate Boniva   
Calcitonin Miacalcin   
Raloxifene Evista   
Teriparatide Forteo  
  1. This table illustrates the direction of change in fracture risk with each type of drug. This does not represent a comparison of the magnitude of fracture risk reduction with different drugs. While all FDA-approved medications have been shown to reduce the risk of spine fracture, only estrogen, alendronate, and risedronate have reduced the risk of hip fracture in randomized placebo-controlled trials.